Amgen, Inc. (AMGN)
429.88
-2.54
(-0.59%)
USD |
NASDAQ |
Aug 31, 16:00
433.00
+3.12
(+0.73%)
After-Hours: 20:00
Amgen Research and Development Expense (Annual) : 6.974B for Dec. 31, 2025
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 6.974B |
| December 31, 2024 | 5.676B |
| December 31, 2023 | 4.755B |
| December 31, 2022 | 4.434B |
| December 31, 2021 | 4.819B |
| December 31, 2020 | 4.207B |
| December 31, 2019 | 4.116B |
| December 31, 2018 | 3.737B |
| December 31, 2017 | 3.562B |
| December 31, 2016 | 3.84B |
| December 31, 2015 | 4.07B |
| December 31, 2014 | 4.248B |
| December 31, 2013 | 4.083B |
| December 31, 2012 | 3.38B |
| December 31, 2011 | 3.167B |
| December 31, 2010 | 2.824B |
| December 31, 2009 | 2.788B |
| December 31, 2008 | 3.027B |
| December 31, 2007 | 3.176B |
| Date | Value |
|---|---|
| December 31, 2006 | 3.318B |
| December 31, 2005 | 2.314B |
| December 31, 2004 | 2.028B |
| December 31, 2003 | 1.655B |
| December 31, 2002 | 1.117B |
| December 31, 2001 | 865.00M |
| December 31, 2000 | 845.00M |
| December 31, 1999 | 822.80M |
| December 31, 1998 | 663.30M |
| December 31, 1997 | 630.80M |
| December 31, 1996 | 528.30M |
| December 31, 1995 | 451.70M |
| December 31, 1994 | 323.63M |
| December 31, 1993 | 255.32M |
| December 31, 1992 | 182.30M |
| December 31, 1991 | 120.94M |
| March 31, 1990 | 62.53M |
| March 31, 1989 | 52.04M |
| March 31, 1988 | 39.63M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Gilead Sciences, Inc. | 5.688B |
| Regeneron Pharmaceuticals, Inc. | 5.306B |
| AbbVie, Inc. | 8.249B |
| Biogen, Inc. | 1.481B |
| Vertex Pharmaceuticals, Inc. | 3.754B |